The evolution of medulloblastoma therapy to personalized medicine [version 1; referees: 3 approved]

The evolution of medulloblastoma therapy to personalized medicine [version 1; referees: 3 approved]

Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signal...

Full description

Bibliographic Details
Main Authors:	Soma Sengupta, Daniel Pomeranz Krummel, Scott Pomeroy
Format:	Article
Language:	English
Published:	F1000 Research Ltd 2017-04-01
Series:	F1000Research
Subjects:	Cancer Therapeutics Developmental & Pediatric Neurology Medical Genetics Neurobiology of Disease & Regeneration Neuro-Oncology Neuropharmacology & Psychopharmacology Pediatric Oncology
Online Access:	https://f1000research.com/articles/6-490/v1

Similar Items

New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND) [version 1; referees: 3 approved]
by: Tanjala T. Gipson, et al.
Published: (2017-06-01)

Recent advances in predicting responses to antidepressant treatment [version 1; referees: 2 approved]
by: Thomas Frodl
Published: (2017-05-01)

Fragile X syndrome and fragile X-associated disorders [version 1; referees: 2 approved]
by: Akash Rajaratnam, et al.
Published: (2017-12-01)

Recent advances in the understanding and management of bipolar disorder in adults [version 1; referees: 2 approved]
by: Janusz K. Rybakowski
Published: (2017-11-01)

Tourette syndrome research highlights 2015 [version 1; referees: 3 approved]
by: Cheryl A. Richards, et al.
Published: (2016-06-01)

Recent advances in treating Parkinson’s disease [version 1; referees: 2 approved]
by: Wolfgang H. Oertel
Published: (2017-03-01)

Recent advances in understanding maternal perinatal mood disorders [version 1; referees: 2 approved]
by: Thalia Robakis, et al.
Published: (2017-06-01)

Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndrome [version 1; referees: 2 approved]
by: Anna Pinto, et al.
Published: (2016-03-01)

Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective [version 1; referees: 2 approved]
by: Lara Hwa, et al.
Published: (2017-03-01)

Disinhibition, an emerging pharmacology of learning and memory [version 1; referees: 3 approved]
by: Hanns Möhler, et al.
Published: (2017-02-01)

Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis [version 2; referees: 2 approved]
by: Mary A. Bitta, et al.
Published: (2017-06-01)

The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system? [version 1; referees: 2 approved]
by: Norman R. Saunders, et al.
Published: (2016-03-01)

Recent advances in the management and understanding of macular degeneration [version 1; referees: 2 approved]
by: Sepehr Bahadorani, et al.
Published: (2017-04-01)

Chemotherapy-induced peripheral neuropathy: an update on the current understanding [version 1; referees: 2 approved]
by: James Addington, et al.
Published: (2016-06-01)

Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way? [version 1; referees: 2 approved]
by: Giovanni Grasso, et al.
Published: (2016-05-01)

Is suvorexant a better choice than alternative hypnotics? [version 1; referees: 2 approved]
by: Daniel F. Kripke
Published: (2015-08-01)

Progress toward an integrated understanding of Parkinson's disease [version 1; referees: 2 approved]
by: Maxime W.C. Rousseaux, et al.
Published: (2017-07-01)

Risk of intracranial hemorrhage in users of oral antithrombotic drugs: Study protocol for a nationwide study [version 1; referees: 2 approved]
by: Sasha Gulati, et al.
Published: (2015-12-01)

Disorders of neuronal migration /
by: Barth, Peter G., et al.
Published: (2003)

Improving outcome of sensorimotor functions after traumatic spinal cord injury [version 1; referees: 2 approved]
by: Volker Dietz
Published: (2016-05-01)

Recent advances in managing a spinal cord injury secondary to trauma [version 1; referees: 2 approved]
by: Christopher S. Ahuja, et al.
Published: (2016-05-01)

Understanding the role of serotonin in psychiatric diseases [version 1; referees: 3 approved]
by: Donatella Marazziti
Published: (2017-02-01)

Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials [version 1; referees: 2 approved]
by: Frank Lieberman
Published: (2017-10-01)

Case Report: Sciatic nerve schwannoma - a rare cause of sciatica [version 1; referees: 2 approved]
by: Sunil Munakomi, et al.
Published: (2017-03-01)

Case Report: Multiple hemorrhagic metastases to the brain from primary lung choriocarcinoma [version 1; referees: 2 approved]
by: Sunil Munakomi
Published: (2017-05-01)

Tourette Syndrome research highlights 2014 [version 2; referees: 1 approved, 2 approved with reservations]
by: Cheryl A Richards, et al.
Published: (2015-07-01)

Pathophysiological links between traumatic brain injury and post-traumatic headaches [version 1; referees: 3 approved]
by: Robert L. Ruff, et al.
Published: (2016-08-01)

Non-cellular immunotherapies in pediatric central nervous system tumors
by: Sarah Rumler
Published: (2023-10-01)

Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma [version 1; referees: 2 approved]
by: Miguel-Angel Díaz-Castellanos, et al.
Published: (2017-12-01)

Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome Predictions
by: Musa Alharbi, et al.
Published: (2020-03-01)

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 3; referees: 2 approved]
by: Daniel F. Kripke
Published: (2018-11-01)

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 2; referees: 2 approved]
by: Daniel F. Kripke
Published: (2017-03-01)

Recent advances in the management of migraine [version 1; referees: 3 approved]
by: Mark Obermann, et al.
Published: (2016-11-01)

Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease [version 1; referees: 3 approved]
by: Masanobu Kano, et al.
Published: (2017-04-01)

New drugs in psychiatry: focus on new pharmacological targets [version 1; referees: 3 approved]
by: Filippo Caraci, et al.
Published: (2017-03-01)

Serotonin receptors in depression: from A to B [version 1; referees: 3 approved]
by: Katherine M. Nautiyal, et al.
Published: (2017-02-01)

Functional assessment of the NMDA receptor variant GluN2AR586K [version 1; referees: 1 approved, 2 approved with reservations]
by: Katie F.M. Marwick, et al.
Published: (2017-03-01)

Case Report: Primary dural based diffuse large B-Cell lymphoma in a 14 year-old boy [v1; ref status: indexed, http://f1000r.es/56s]
by: Sunil Munakomi, et al.
Published: (2015-03-01)

Dysmenorrhea and related disorders [version 1; referees: 3 approved]
by: Mariagiulia Bernardi, et al.
Published: (2017-09-01)

Upper extremity nerve block: how can benefit, duration, and safety be improved? An update [version 1; referees: 3 approved]
by: Metha Brattwall, et al.
Published: (2016-05-01)